| Mrs Elise Reeves, CRNA | |
|
215 Marion Ave, Mccomb, MS 39648-2705 | |
| (601) 249-5500 | |
| Not Available |
| Full Name | Mrs Elise Reeves |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 9 Years |
| Location | 215 Marion Ave, Mccomb, Mississippi |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497138598 | NPI | - | NPPES |
| 07829507 | Medicaid | MS | |
| AP08334 | Other | LA | LA LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | R883639 (Mississippi) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lallie Kemp Medical Center | Independence, LA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Lallie Kemp Medical Ctr | 0345238903 | 37 |
| Youngs Professional Services Llc | 2163524992 | 239 |
| North Oaks Medical Center, Llc | 2466629522 | 228 |
News Archive
The brain's neural activity-;long implicated in disorders ranging from dementia to epilepsy-;also plays a role in human aging and life span, according to research led by scientists in the Blavatnik Institute at Harvard Medical School.
Anadys Pharmaceuticals, Inc. has announced that the U.S. Food and Drug Administration (FDA) has granted fast track designation to ANA598 for the treatment of chronic hepatitis C virus (HCV) infection. ANA598 is Anadys' investigational hepatitis C non-nucleoside polymerase inhibitor.
There are three common drugs for advanced ovarian cancer: paclitaxel, cyclophosphamide, and topotecan. Like a shell game, if you pick the right drug a patient is likely to respond. And, unfortunately, picking the wrong drug can lead to treatment failure. As reported in this month's issue of the journal PLoS ONE, a University of Colorado Cancer Center and University of Virginia study used a sophisticated model of ovarian cancer genetics to match the right tumor with the right drug. Patients who were matched in this way lived an average 21 months longer than patients who were not matched.
Gastroesophageal reflux disease (GERD) is a debilitating problem for sufferers - heartburn, difficulty swallowing, chest pain and acid reflux. According to a Mayo Clinic study that will be presented at Digestive Disease Week (DDW) 2010 in New Orleans May 1-5, even moderate weight gain can exacerbate those symptoms, DDW is the largest international gathering of physicians and researcher in the field of gastroenterology, hepatology, endoscopy and gastrointestinal surgery.
› Verified 2 days ago
| Entity Name | Lallie Kemp Medical Ctr |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558303420 PECOS PAC ID: 0345238903 Enrollment ID: O20040503001188 |
News Archive
The brain's neural activity-;long implicated in disorders ranging from dementia to epilepsy-;also plays a role in human aging and life span, according to research led by scientists in the Blavatnik Institute at Harvard Medical School.
Anadys Pharmaceuticals, Inc. has announced that the U.S. Food and Drug Administration (FDA) has granted fast track designation to ANA598 for the treatment of chronic hepatitis C virus (HCV) infection. ANA598 is Anadys' investigational hepatitis C non-nucleoside polymerase inhibitor.
There are three common drugs for advanced ovarian cancer: paclitaxel, cyclophosphamide, and topotecan. Like a shell game, if you pick the right drug a patient is likely to respond. And, unfortunately, picking the wrong drug can lead to treatment failure. As reported in this month's issue of the journal PLoS ONE, a University of Colorado Cancer Center and University of Virginia study used a sophisticated model of ovarian cancer genetics to match the right tumor with the right drug. Patients who were matched in this way lived an average 21 months longer than patients who were not matched.
Gastroesophageal reflux disease (GERD) is a debilitating problem for sufferers - heartburn, difficulty swallowing, chest pain and acid reflux. According to a Mayo Clinic study that will be presented at Digestive Disease Week (DDW) 2010 in New Orleans May 1-5, even moderate weight gain can exacerbate those symptoms, DDW is the largest international gathering of physicians and researcher in the field of gastroenterology, hepatology, endoscopy and gastrointestinal surgery.
› Verified 2 days ago
| Entity Name | Youngs Professional Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922178599 PECOS PAC ID: 2163524992 Enrollment ID: O20070226000608 |
News Archive
The brain's neural activity-;long implicated in disorders ranging from dementia to epilepsy-;also plays a role in human aging and life span, according to research led by scientists in the Blavatnik Institute at Harvard Medical School.
Anadys Pharmaceuticals, Inc. has announced that the U.S. Food and Drug Administration (FDA) has granted fast track designation to ANA598 for the treatment of chronic hepatitis C virus (HCV) infection. ANA598 is Anadys' investigational hepatitis C non-nucleoside polymerase inhibitor.
There are three common drugs for advanced ovarian cancer: paclitaxel, cyclophosphamide, and topotecan. Like a shell game, if you pick the right drug a patient is likely to respond. And, unfortunately, picking the wrong drug can lead to treatment failure. As reported in this month's issue of the journal PLoS ONE, a University of Colorado Cancer Center and University of Virginia study used a sophisticated model of ovarian cancer genetics to match the right tumor with the right drug. Patients who were matched in this way lived an average 21 months longer than patients who were not matched.
Gastroesophageal reflux disease (GERD) is a debilitating problem for sufferers - heartburn, difficulty swallowing, chest pain and acid reflux. According to a Mayo Clinic study that will be presented at Digestive Disease Week (DDW) 2010 in New Orleans May 1-5, even moderate weight gain can exacerbate those symptoms, DDW is the largest international gathering of physicians and researcher in the field of gastroenterology, hepatology, endoscopy and gastrointestinal surgery.
› Verified 2 days ago
| Entity Name | North Oaks Medical Center, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972630705 PECOS PAC ID: 2466629522 Enrollment ID: O20120117000359 |
News Archive
The brain's neural activity-;long implicated in disorders ranging from dementia to epilepsy-;also plays a role in human aging and life span, according to research led by scientists in the Blavatnik Institute at Harvard Medical School.
Anadys Pharmaceuticals, Inc. has announced that the U.S. Food and Drug Administration (FDA) has granted fast track designation to ANA598 for the treatment of chronic hepatitis C virus (HCV) infection. ANA598 is Anadys' investigational hepatitis C non-nucleoside polymerase inhibitor.
There are three common drugs for advanced ovarian cancer: paclitaxel, cyclophosphamide, and topotecan. Like a shell game, if you pick the right drug a patient is likely to respond. And, unfortunately, picking the wrong drug can lead to treatment failure. As reported in this month's issue of the journal PLoS ONE, a University of Colorado Cancer Center and University of Virginia study used a sophisticated model of ovarian cancer genetics to match the right tumor with the right drug. Patients who were matched in this way lived an average 21 months longer than patients who were not matched.
Gastroesophageal reflux disease (GERD) is a debilitating problem for sufferers - heartburn, difficulty swallowing, chest pain and acid reflux. According to a Mayo Clinic study that will be presented at Digestive Disease Week (DDW) 2010 in New Orleans May 1-5, even moderate weight gain can exacerbate those symptoms, DDW is the largest international gathering of physicians and researcher in the field of gastroenterology, hepatology, endoscopy and gastrointestinal surgery.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Elise Reeves, CRNA 215 Marion Ave, Mccomb, MS 39648-2705 Ph: (601) 249-1802 | Mrs Elise Reeves, CRNA 215 Marion Ave, Mccomb, MS 39648-2705 Ph: (601) 249-5500 |
News Archive
The brain's neural activity-;long implicated in disorders ranging from dementia to epilepsy-;also plays a role in human aging and life span, according to research led by scientists in the Blavatnik Institute at Harvard Medical School.
Anadys Pharmaceuticals, Inc. has announced that the U.S. Food and Drug Administration (FDA) has granted fast track designation to ANA598 for the treatment of chronic hepatitis C virus (HCV) infection. ANA598 is Anadys' investigational hepatitis C non-nucleoside polymerase inhibitor.
There are three common drugs for advanced ovarian cancer: paclitaxel, cyclophosphamide, and topotecan. Like a shell game, if you pick the right drug a patient is likely to respond. And, unfortunately, picking the wrong drug can lead to treatment failure. As reported in this month's issue of the journal PLoS ONE, a University of Colorado Cancer Center and University of Virginia study used a sophisticated model of ovarian cancer genetics to match the right tumor with the right drug. Patients who were matched in this way lived an average 21 months longer than patients who were not matched.
Gastroesophageal reflux disease (GERD) is a debilitating problem for sufferers - heartburn, difficulty swallowing, chest pain and acid reflux. According to a Mayo Clinic study that will be presented at Digestive Disease Week (DDW) 2010 in New Orleans May 1-5, even moderate weight gain can exacerbate those symptoms, DDW is the largest international gathering of physicians and researcher in the field of gastroenterology, hepatology, endoscopy and gastrointestinal surgery.
› Verified 2 days ago
Mr. Jason Todd Lane, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 215 Marion Ave, Mccomb, MS 39648 Phone: 601-249-5500 Fax: 601-249-1709 | |
Mr. Hugh Russell Fortenberry Jr., CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 215 Marion Ave, Mccomb, MS 39648 Phone: 601-249-5500 Fax: 601-249-1709 | |
Mr. George Rayford Smith Ii, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 215 Marion Dr., Mccomb, MS 39648 Phone: 601-249-5500 | |
Rachel Spiers, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 215 Marion Ave, Mccomb, MS 39648 Phone: 601-249-1183 | |
Irby Lee Campbell, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 215 Marion Ave, Mccomb, MS 39648 Phone: 601-249-1183 Fax: 601-249-1709 | |
Mrs. Sarah Dart Andrews, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 215 Marion Ave, Mccomb, MS 39648 Phone: 601-249-5500 Fax: 601-249-1709 | |
Anesha Handshaw, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 215 Marion Ave, Mccomb, MS 39648 Phone: 601-249-5500 |